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The dysfunction of cholinergic neurons is a typical hallmark in Alzheimer’s disease (AD).
Previous findings demonstrated that high density of cholinergic receptors is found in the
thalamus and the cerebellum compared with the cerebral cortex and the hippocampus.
We aimed at investigating whether activation of the cerebello-thalamo-cortical pathway
by means of cerebellar theta burst stimulation (TBS) could modulate central cholinergic
functions evaluated in vivo by using the neurophysiological determination of Short-Latency
Afferent Inhibition (SLAI). We tested the SLAI circuit before and after administration
of cerebellar continuous TBS (cTBS) in 12 AD patients and in 12 healthy age-matched
control subjects (HS). We also investigated potential changes of intracortical circuits of the
contralateral primary motor cortex (M1) by assessing short intracortical inhibition (SICI)
and intracortical facilitation (ICF). SLAI was decreased in AD patients compared to HS.
Cerebellar cTBS partially restored SLAI in AD patients at later inter-stimulus intervals (ISIs),
but did not modify SLAI in HS. SICI and ICF did not differ in the two groups and were
not modulated by cerebellar cTBS. These results demonstrate that cerebellar magnetic
stimulation is likely to affect mechanisms of cortical cholinergic activity, suggesting that
the cerebellum may have a direct influence on the cholinergic dysfunction in AD.
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INTRODUCTION
Alzheimer’s disease (AD) pathophysiology is dominated by a dys-
function of the central cholinergic system. In AD patients, the
impairment of central cholinergic functions can be evaluated
in vivo by using a neurophysiological effect called Short-Latency
Afferent Inhibition (SLAI) (Tokimura et al., 2000). SLAI consists
in the inhibition of the Motor Evoked Potentials (MEPs) by affer-
ent sensory impulses. SLAI can be easily measured by applying an
electric conditioning pulse on the median nerve at wrist that pre-
cedes the TMS test pulse applied over the contralateral primary
motor cortex (M1) by 20–25ms. SLAI is abolished by scopo-
lamine, a potent muscarinic antagonist (Di Lazzaro et al., 2002),
and it has therefore been suggested that the inhibitory effect of
peripheral stimulation ismediated by cholinergic projections over
the primary motor cortex. In AD patients, SLAI is reduced to var-
ious degrees depending on the severity of the disease, so that the
decreased inhibitory effect of peripheral stimulation is thought to
reflect the cholinergic dysfunction in AD (Di Lazzaro et al., 2002;
Martorana et al., 2009).
Although the cerebellum is not among the most renown brain
structures to be affected by the pathology, recent evidence sug-
gested that it undergoes degenerative changes in AD: the posterior
cerebellar lobes are significantly smaller in AD patients when
compared to HC, and atrophy of the posterior cerebellar regions
is associated with poorer cognitive performance (Thomann et al.,
2008). Moreover, the cerebellum is strongly involved in cholin-
ergic functions. A recent PET study demonstrated that intra-
venously administered [11C]-donepezil, an acetyl-cholinesterase
(AChE) inhibitor used in AD therapy, rapidly enters the brain
and mainly distributes to the striatum, thalamus, and cerebellum,
which are known to contain high densities of AChE compared
with the cerebral cortex and hippocampus (Okamura et al., 2008).
The regional distribution of [11C]-donepezil was consistent with
regional AChE activity determined in a human postmortem study
(Finkelstein et al., 1988). Moreover, nicotinic cholinergic recep-
tors (nAChRs) are widely distributed in the mammalian cerebel-
lum and are known to regulate synaptic efficacy at two major
classes of cerebellar neurons (Turner et al., 2011; D’Angelo and
Casali, 2012).
In humans, the neural activity of the cerebellum can be
explored in vivo by means of repetitive transcranial magnetic
stimulation (Ugawa et al., 1995; Del Olmo et al., 2007; Koch
et al., 2008). Therefore, in the current study, we sought to inves-
tigate whether cerebellar magnetic stimulation could modulate
the altered SLAI circuits described in AD patients. We reasoned
that given that the cerebellar activity is involved in the choliner-
gic system, cerebellar continuous TBS (cTBS) could provide novel
information regarding the interactions between the cerebello-
thalamo-cortical circuits and the central cholinergic functioning
in AD patients.
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MATERIALS AND METHODS
SUBJECTS
We examined 12 patients with a new diagnosis of probable
AD according to the NINCDS-ADRDA criteria (Varma et al.,
1999) and 12 neurologically healthy age-matched control sub-
jects (HS). The mean (±SD) age of the patients was 69.8 (±4.9)
years, whereas that of controls was 71.7 (±4.4) years. All patients
underwent a complete clinical investigation, including medical
history, neurological examination, mini mental state examination
(MMSE), a complete blood screening (including routine exams,
thyroid hormones, level of B12), neuropsychological examina-
tion, a complete neuropsychiatric evaluation, and morphological
magnetic resonance imaging (1.5 T MRI). Exclusion criteria were
the following: patients with isolated deficits and/or unmodified
MMSE (≥25/30) on revisit (6, 12, and 18 months follow-up),
patients with clinically manifest acute stroke in the last 6 months
showing Hachinsky scale score>4, and a radiological evidence of
sub-cortical lesions. None of patients revealed pyramidal and/or
extrapyramidal signs at the neurological examination. At the
time of enrolment, in the 30 days before participating in this
study, none of the patients had been treated with drugs that
might have modulated cerebral cortex excitability such as antide-
pressants, or any other neuroactive drugs (i.e., benzodiazepines,
anti-epileptic drugs, or neuroleptics), and they had not been
treated with cholinesterase inhibitors. All AD patients showed a
cognitive profile consistent with moderate dementia, as assessed
by a neuropsychological evaluation including the MMSE and a
standardized neuropsychological battery (Carlesimo et al., 1996).
On the MMSE, AD patients scored a mean of 21.08 (±3.9) and
Clinical Dementia Rating (CDR) was 1.21 (±1.1). All partic-
ipants or their legal guardian gave the written informed con-
sent after receiving an extensive disclosure of study. The study
was performed according to the Declaration of Helsinki and
approved by the ethics committee of the Tor Vergata University
in Rome.
EXPERIMENT 1: EFFECTS OF CEREBELLAR cTBS ON SLAI, SICI,
AND ICF CIRCUITS
SLAI
Magnetic stimulation was performed using an high power
Magstim 200 magnetic stimulator (Magstim Co, Whitland,
Dyfed, UK). The magnetic stimuli had a nearly monophasic
pulse configuration, with a rise time of 0.1ms, decaying back
to zero over 0.8ms. A figure of eight coil with external loop
diameters of 9 cm was held over the left motor cortex at the
optimum scalp position to elicit motor responses in the contralat-
eral first dorsal interosseous (FDI) muscle. The optimal position
was marked on the scalp with a felt pen to ensure identical
placement of the coil throughout the experiment. The handle
of the coil pointed backward and was perpendicular to the pre-
sumed direction of the central sulcus, about 45◦ to the midsagittal
line. The direction of the induced current was from posterior
to anterior and was optimal to activate the motor cortex trans-
synaptically. Surface muscle responses were recorded via two
9mm diameter Ag–AgCl electrodes with the active electrode over
the motor point of the muscle and the reference on the metacar-
pophalangeal joint of the index finger. Muscle responses were
amplified and filtered (bandwidth 3–3000Hz) by D150 ampli-
fiers (Digitimer, Welwyn Garden City, Hertfordshire, UK). Data
were collected on a computer with a sampling rate of 10 kHz per
channel and stored for later analysis using a CED 1401 A–D con-
verter (Cambridge Electronic Design, Cambridge, UK). All the
AD patients selected were able to understand and carry out the
simple task required for this electrophysiological study—that is,
to keep fully relaxed.
The resting motor threshold (RMT) was defined as the low-
est intensity that produced MEPs of >50µV in at least five
out of 10 trials with the muscles relaxed (Rossini et al., 1994).
Determination of RMT was done in step width of 1% of maximal
stimulator output (MSO). Short latency inhibition was studied
using the technique that has been recently described (Tokimura
et al., 2000) (see Figure 1). Conditioning stimuli were single
pulses (200µs) of electrical stimulation applied through bipo-
lar electrodes to the right median nerve at the wrist (cathode
proximal). The intensity of the conditioning stimulus was set
at just over motor threshold for evoking a visible twitch of
the thenar muscles. The intensity of the test cortical magnetic
stimulus was adjusted to evoke a muscle response in relaxed
right FDI with amplitude of approximately 1mV peak to peak.
The conditioning stimulus to the peripheral nerve preceded
the magnetic test stimulus by different interstimulus intervals
(ISIs). ISIs were determined relative to the latency of the N20
component of the somatosensory evoked potential induced by
stimulation of the right median nerve. The active electrode
for recording the N20 potential was attached 3 cm posterior
to C3 (10–20 system) and the reference was 3 cm posterior
to C4. Five hundred responses were averaged to identify the
latency of the N20 peak. ISIs from N20 −4ms to N20 +8ms
were investigated in 4ms steps. Ten stimuli were delivered at
each ISI. The subject was given audiovisual feedback at high
gain to assist in maintaining complete relaxation. The inter-
trial interval was set at 5 s (±10%), for a total duration of
approximately 5min. Measurements were made on each individ-
ual trial. The mean peak-to peak amplitude of the conditioned
MEP at each ISI was expressed as a percentage of the mean
peak-to-peak amplitude size of the unconditioned test pulse in
that block.
SICI-ICF
We used a 7 cm figure-of-eight coil connected with two Magstim
200 stimulators to apply paired TMS over the motor cortex. In
order to investigate M1 intracortical circuits such as short intra-
cortical inhibition (SICI) and intracortical facilitation (ICF). The
magnetic stimuli had a nearly monophasic pulse configuration.
The coil was placed at the optimal position for eliciting MEPs
from the left contralateral FDI muscle. SICI and ICF were tested
using paired TMS with a conditioning stimulus (CS) preceding a
test stimulus (TS) by 1–15ms (Kujirai et al., 1993; Ziemann et al.,
1996). CS was set at 80% AMT (Huang and Rothwell, 2004) while
the intensity of TS was adjusted to evoke a MEP of approximately
1mV peak to peak in the relaxed FDI. The amplitude of the con-
ditioned MEP at each ISI was expressed as a percentage of the
mean peak-to-peak amplitude size of the unconditioned TS in
that block.
Frontiers in Aging Neuroscience www.frontiersin.org February 2013 | Volume 5 | Article 2 | 2
Di Lorenzo et al. AD cholinergic dysfunction cerebellar modulation
FIGURE 1 | Schematic description of the experimental procedure.
Short-latency afferent inhibition (SLAI) was recorded by measuring the
inhibitory effects of the peripheral median nerve stimulation over the amplitude
of the MEP recorded from the right FDI at different interstimulus intervals in
AD patients and age matched healthy controls. SLAI wasmeasured at baseline
and after a session of cTBS over the left lateral cerebellum in both groups.
cTBS
A MagStim Super Rapid magnetic stimulator (Magstim
Company, Whitland, Wales, UK), connected with a figure-of-
eight coil with a diameter of 70mm was used to deliver cTBS.
Three-pulse bursts at 50Hz repeated every 200ms for 40 s were
delivered at 80% of the active motor threshold (AMT) over the
lateral cerebellum (600 pulses) (Huang et al., 2005). cTBS was
applied over the right lateral cerebellum using the same scalp
co-ordinates (1 cm inferior and 3 cm left/right to the inion)
adopted in previous MRI studies showing that this site target
the posterior and superior lobules of the lateral cerebellum (Del
Olmo et al., 2007). We used the figure-of-eight coil, since this
approach has been adopted in previous investigations in which
cerebellar rTMS was shown to be effective in modulating the
excitability of the contralateral motor cortex (Del Olmo et al.,
2007). The coil was positioned tangentially to the scalp, with the
handle pointing superiorly.
SLAI and SICI/ICF were tested before in two different blocks
and immediately after the application of cTBS over the right lat-
eral cerebellum. The order of presentation of the blocks before
and after cTBS was pseudo-randomized across subjects.
EXPERIMENT 2: EFFECTS OF CEREBELLAR cTBS ON SLAI
INPUT-OUTPUT CURVES IN HEALTHY SUBJECTS
SLAI is already different between groups (less in AD) at baseline.
Therefore, it is unclear how to interpret the effects of cerebellar
cTBS. From the reported data, the possibility cannot be excluded
that the modulating cTBS effect was not seen in the healthy con-
trols merely due to SLAI saturation (floor effect). To disentangle
this, we performed an experiment in which we studied SLAI
input-output curves by systematic variation of the intensity of the
peripheral nerve stimulus to compare the effects of cTBS at equiv-
alent SLAI levels as those obtained in the AD patients group. In a
group of eight healthy controls SLAI was tested as in Experiment
1, but three different blocks were applied. In each block the inten-
sity of the peripheral nerve stimulation was set at 100, 200, and
300% of the sensory threshold (ST) (note that an intensity of
300% is close to the one necessary for evoking a visible twitch of
the thenar muscles as in Experiment 1). SLAI blocks were tested
before and immediately after the application of cTBS over the
right lateral cerebellum. The order of presentation of the blocks
before and after cTBS was pseudo-randomized across subjects.
EXPERIMENT 3: EFFECTS OF OCCIPITAL cTBS ON SLAI, SICI, AND ICF
CIRCUITS
We performed an additional experiment in order to exclude that
the cTBS effects obtained in the AD patients could be non-
specific. Therefore, we performed the same experiment as in
Experiment 1 but we varied the site of application of cTBS, by
choosing the occipital cortex as a control area. The occipital TMS
site was 3 cm above the inion and 1 cm right of midline (Romei
et al., 2012). SLAI and SICI/ICF were tested before in two differ-
ent blocks and immediately after the application of cTBS over the
right lateral cerebellum. The order of presentation of the blocks
before and after cTBS was pseudo-randomized across subjects.
STATISTICAL ANALYSIS
In Experiment 1 SLAI parameters of AD patients were compared
with those of controls by means of repeated measures ANOVA
with GROUP (AD vs. healthy subjects) as between subjects factor
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and ISI (−4, 0, +4, and +8ms plus the latency of the N20) and
PROTOCOL (pre vs. post cTBS) as within subjects factors. For
SICI we performed a repeated measures analysis ANOVA with
GROUP (AD vs. healthy subjects) as between subjects’ factor and
ISI (1, 2, 3, 5, 7, 10, and 15ms) and PROTOCOL (pre vs. post
cTBS) as within subjects factors. In experiment 2 we performed
a repeated measures ANOVA with INTENSITY (100, 200, and
300% of ST), ISI (−4, 0, +4, and +8ms plus the latency of the
N20) and PROTOCOL (pre vs. post cTBS) as within subjects
factors. In Experiment 3 SLAI parameters of AD patients were
analysed by means of repeated measures ANOVA with ISI (−4,
0, +4, and +8ms plus the latency of the N20) and PROTOCOL
(pre vs. post cTBS) as within subjects factors. When a significant
main effect was reached, paired t-tests with Bonferroni correction
were employed to characterize the different effects of the specific
ISIs. For all statistical analyses, a p value of <0.05 was considered
to be significant. Mauchley’s test examined for sphericity. The
Greenhouse–Geisser correction was used for non-spherical data.
RESULTS
EXPERIMENT 1
The N20 latency and amplitude were within normal limits in
all AD patients and control subjects and did not differ between
the two groups (20.5 ± 3.2ms vs. 20.8 ± 2.9ms). The mean
(SD) RMT to TMS was significantly lower in AD patients than
in controls (45.9% ± 2.1 vs. 49.9 ± 1.1%) of MSO; t = 3.14;
p < 0.05 (see Table 1). RMT was not significantly modified fol-
lowing cerebellar cTBS (p = 0.48 at paired t-test analysis). For
unconditioned, TS MEPs amplitude pre and post cTBS did not
differ being, respectively, 1.08 ± 0.33mV and 1.04 ± 0.31mV in
AD and 1.13± 0.25mV and 1.14± 0.34mV in controls. Repeated
ANOVA performed on SLAI measures revealed significant main
effects of PROTOCOL (F = 5.66; p = 0.027) and ISI (F = 19.14;
p = 0.0001), as well significant GROUP × PROTOCOL (F =
4.26; p = 0.041) interaction. The triple interaction GROUP ×
Table 1 | Parameters of corticospinal excitability before and after
cTBS.
Measures AD HS
rMT (%) 45.9 ± 2.1 49.9 ± 1.1
aMT (%) 34 ± 1.3 37 ± 1.9
1mV (%) 52.41 ± 2.8 55.4 ± 2.2
PRE cTBS
ICI 2ms (%) 42.85 ± 7.2 65 ± 10.6
ICF 15ms (%) 99.22 ± 9.0 136.9 ± 9.1
SLAI 24ms (%) 75.4 ± 13.5 57.7 ± 9.8
POST cTBS
ICI 2ms (%) 41.77 ± 6.1 60.32 ± 9.6
ICF 15ms (%) 118 ± 12.1 136.5 ± 27
SLAI 24ms (%) 53.147 ± 4.9 63.4 ± 8.8
rMT, resting motor threshold; aMT, active motor threshold; 1mV, intensity of
magnetic stimulus adjusted to evoke 1mV peak to peak MEP; ICI, intracorti-
cal inhibition; SLAI, short-latency afferent inhibition. For the threshold values,
“%” are related to the maximal stimulator output (MSO); for SICI, ICF and SLAI
values, “%” are related to the control MEP amplitude.
ISI × PROTOCOL was not significant. Post hoc analysis revealed
that at baseline the amount of SLAI inhibition was smaller in
AD patients than in normal controls at +4 and +8ms (all p <
0.05) (Figure 2). The amount of SLAI inhibition increased in
AD patients following cTBS at 0 and +4ms ISIs (all p < 0.05)
(Figure 3A). On the other hand when the same analysis was
performed in the HS group, no significant difference emerged
(Figure 3B). No effects were found for SICI and ICF in both
groups. (Figures 4A,B).
EXPERIMENT 2
Repeated ANOVA performed on SLAI measures revealed signif-
icant main effects of INTENSITY (F = 2.14; p = 0.036) and ISI
(F = 2.64; p = 0.04), but no a significant cTBS effect (Figure 5).
All the interactions were not significant. These data indicate
that the cTBS effects observed in Experiment 1 were specific for
the AD patients and did not depend on a different basal level
of SLAI.
FIGURE 2 | (A) Short-latency afferent inhibition (SLAI) at different
interstimulus intervals in AD patients (open squares) and control (black
diamonds) subjects. The interval between median nerve stimulation and
cortical stimuli was corrected for the latency of the N20 component of the
somatosensory evoked potential in each subject (see text). The size of
MEPs is expressed as a percentage of the MEP evoked by magnetic
stimulation alone. (B) Short intracortical inhibition (SICI) and intracortical
facilitation (ICF) at different interstimulus intervals in AD patients (open
squares) and control subjects (black diamonds). The size of MEPs is
expressed as a percentage of the MEP evoked by magnetic stimulation
alone. Error bars indicate mean standard errors. ∗p < 0.05.
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FIGURE 3 | Effects of cerebellar cTBS on SLAI (A) and SICI (B) in AD
patients. Error bars indicate standard deviations. The size of MEPs is
expressed as a percentage of the MEP evoked by magnetic stimulation
alone. Error bars indicate mean standard errors.
EXPERIMENT 3
Repeated ANOVA performed on SLAI measures revealed a signif-
icant main effect of ISI (F = 4.04; p = 0.023), but no effect for
cTBS main factor and for the cTBS × ISI interaction (Figure 6).
DISCUSSION
The current results confirmed previous studies showing that SLAI
of the motor cortex is significantly reduced in AD patients com-
pared to age matched normal subjects (i.e., Di Lazzaro et al.,
2002; Freitas et al., 2011). Notably, we found that such SLAI
dis-inhibition is restored following a single session of cerebellar
cTBS. Our results therefore seem to suggest that the activation of
cerebello-thalamo-cortical pathway by means of cerebellar cTBS
is able to modulate SLAI function in AD patients. Although
SLAI is considered a hallmark of central cholinergic function
that is thought to depend on the integrity of cortico-cortical
inhibitory circuits (Tokimura et al., 2000), its current interpre-
tation is still debated. Acetylcholine is thought to be involved
in modulation of intracortical circuits mediated by groups of
GABAergic interneurons, rather than directly acting on pyra-
midal cells (Di Lazzaro et al., 2002, 2004). At this regard, Di
Lazzaro and co-workers (Di Lazzaro et al., 2005) demonstrated
that different types of benzodiazepines such as diazepam and
FIGURE 4 | Effects of cerebellar cTBS on SLAI (A) and SICI and ICF (B)
in healthy subjects. Error bars indicate standard deviations. The size of
MEPs is expressed as a percentage of the MEP evoked by magnetic
stimulation alone. Error bars indicate mean standard errors. ∗p < 0.05.
lorazepam resulted in distinct effects on both SICI and SLAI.
In particular diazepam increased both SLAI and SICI, while
lorazepam reduced SLAI but increased SICI, suggesting that the
interactions between cholinergic and GABAergic circuits may
require the activation of a variety of different receptor sub-
types. Moreover we recently showed that dopamine also plays
a critical role in modulating cortical cholinergic activity, pre-
sumably interacting with such GABAergic intracortical circuits
(Martorana et al., 2009). SLAI starts only a few milliseconds after
the arrival of the somatosensory input at the cortex, and implies
a relatively direct pathway from sensory input to motor output
(Tokimura et al., 2000). The dorsomedial nucleus and intralam-
inar nuclei (thalamic paramedian structures) are under control
of excitatory projections from pontomesencephalic cholinergic
neurons (peduncolopontine and laterodorsal tegmental choliner-
gic nuclei) through muscarinic receptors (Jones, 2003; Steriade,
2004). These pontomesencephalic cholinergic neurons have no
direct projection to the cortex but they do have a prominent
indirect effect on the functional state (and excitability) of corti-
cal neurons as they activate thalamocortical neurons (Steriade,
2004). Consistently with these premises, Oliviero et al. (2005)
reported that, after a thalamic stroke that had destroyed the dor-
somedian and intralaminar nuclei, a patient showed a selective
attenuation of the SLAI in the ipsilesional M1.
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FIGURE 5 | Effects of cerebellar cTBS on SLAI applied with different
intensities of peripheral nerve stimulation in healthy subjects (A) =
100%; (B) = 200%; (C) = 300% of the sensory threshold. Error bars
indicate standard deviations. The size of MEPs is expressed as a
percentage of the MEP evoked by magnetic stimulation alone. Error bars
indicate mean standard errors.
Moreover, cerebellar cTBS is known tomodulate the activation
of cerebello-thalamo-cortical circuits (Koch et al., 2008, 2009). A
recent PET study performed in order to detect the effects induced
by cerebellar cTBS revealed that metabolic changes occur not only
in the cerebellar cortex below the stimulated portion of the cortex
but also in the deep cerebellar nuclei reflecting the activation of
a pathway connecting these regions and likely projecting to the
thalamus (Brusa et al., 2012).
Therefore, one possibility is that cerebellar cTBS could have
increased SLAI efficacy by modulating the gating of the afferent
input at the level of the thalamic nuclei. In fact, the physiology
of the cerebellar-thalamo-cortical pathway activated by magnetic
FIGURE 6 | Effects of occipital cTBS on SLAI in AD patients. Error bars
indicate standard deviations. The size of MEPs is expressed as a
percentage of the MEP evoked by magnetic stimulation alone. Error bars
indicate mean standard errors.
stimulation has been recently clarified. It has been proposed that
cerebellar TMS activates the Purkinje cells of the superior cere-
bellum; such activation results in an inhibition of the dentate
nucleus, which is known to exert a background tonic facilitatory
drive onto the contralateral motor cortex (M1) through synap-
tic relay in the ventral lateral thalamus (Dum and Strick, 2003).
This in turn leads to an inhibition of the contralateral M1, due to
a reduction in dentato-thalamo-cortical facilitatory drive (Ugawa
et al., 1994, 1997; Pinto and Chen, 2001; Daskalakis et al., 2004).
Although apparently SLAI and the cerebello-thalamo-cortical
pathway activated by cerebellar TMS act on different thalamic
nuclei, it has to be considered that intrathalamic connections have
been recently described between thalamic nuclei such as the ven-
troposterior and the medial posterior nucleus (Crabtree et al.,
1998). At this regard, one could argue that the thalamus could
be a plausible site for the interaction occurring between these
two pathways. In alternative, it is possible that the effects that we
observe could depend on an interaction occurring at the level of
the primary motor cortex. Here, complex interactions of intra-
cortical circuits that mediate both the afferent volleys from the
thalamus could be responsible for the observed effects induced by
cerebellar cTBS on SLAI in AD patients.
Another final possibility is that the observed results could
depend on the modulation of cerebellar activity itself, not involv-
ing necessarily interconnected pathways. Notably, the effects of
cerebellar cTBS were evident at later delays (ISIs = +4 and
+8ms). It has been proposed that sensory signals to the motor
cortex arriving at later delays around 25ms (corresponding
approximately to the ISI = 4ms in the current study) are trans-
mitted by a longer polysynaptic pathway which includes the
cerebellum. This view is supported by the literature showing that
the cerebellum receives sensory information (Dean et al., 2010),
and that patients with cerebellar degeneration have abnormal
sensory-motor integration (Tamburin et al., 2003). Accordingly,
recent studies performed in healthy subjects showed that both
transcranial direct stimulation (TDCS) and cTBS applied over
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the cerebellum interfered with the long lasting effects induced by
protocols of paired associative stimulation (PAS) using an electri-
cal stimulus to the median nerve with a TMS pulse given 25ms
later to the motor cortex (Hamada et al., 2012a,b; Popa et al.,
2013). This would explain why in the current study the inter-
action of cerebellar stimulation with sensory-motor integration
is evident only for those stimuli that have longer delays. At this
regard, a large limitation of the current study is that we did not
investigate to which extent the observed SLAI modulation was
eventually associated by changes in cerebello-thalamo-cortical
inhibition (CBI). Thus, it remains to be clarified if there are any
physiological relationships among CBI and SLAI circuits in AD
patients. Moreover we did not even assess changes in MEP sizes
after cerebellar cTBS because our main aim was to study modu-
lation of cholinergic circuits. It has to be acknowledged that this
lack of systematic investigation of test MEP sizes as well as con-
ditioning stimulus intensities for SAI, SICI, and ICF limits the
scientific quality of this paper.
It is important to notice that we did not find the expected
modulation of some intracortical circuits such as SICI in the
primary motor cortex that we previously described following
cerebellar theta burst stimulation (TBS) (Koch et al., 2008). This
could possibly depend on the older age of the healthy controls.
Further experiments would be necessary to better clarify the inter-
play between cerebellar cTBS and cortical excitability. Moreover,
we did not find any difference for SICI and ICF measurements
at baseline between the two groups. This is consistent with the
data presented in a recent review that considers all the studies
evaluating SICI in AD (Freitas et al., 2011): some reductions of
SICI to paired-pulse TMS were found by some investigators, but
most (7 of 11) studies did not find differences in SICI between AD
patients and controls.
Indeed, the effects of cerebellar cTBS were evident only in AD
patients and not in healthy age matched controls. It could well be
that we detected any change in the healthy controls because SLAI
inhibition reached a floor level or, in alternative that such modu-
lation would occur only when a deficient cholinergic innervation
coexists such as in AD patients.
As expected, we found lower RMT in the AD patients group.
It is therefore likely that the I-wave component of the test MEP
sizes (Hamada et al., 2012a,b) would be different between AD
patients and healthy controls. This different amount of I-waves
could have been involved in determining the amount of SLAI and
hence affected the present results. Besides, the conditioning stim-
ulus intensity of SICI and ICF would also be different between
the two groups, and therefore this could be another potential
confounding factor.
Whatever the neurophysiological mechanisms underlying
these complex interactions, the current data suggest that cerebel-
lar magnetic stimulation could be effective in modulating central
cholinergic activity in AD patients. Further studies aimed to
investigate systematically the impact of this protocol on different
cognitive functions would be important to further understand the
potential clinical importance of the current findings.
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